| answer text |
<p>The Department, in consultation with the devolved administrations and Crown Dependencies,
is working with trade bodies, product suppliers, and the health and care system to
help ensure continued supply of medicines and medical products, including medicines
and vaccines related to the treatment of COVID-19, to the whole of the United Kingdom
at the end of the transition period.</p><p>As set out in a letter from the Department
to industry of 17 November, we are implementing a multi-layered approach, that includes
asking suppliers of medicines, vaccines and other medical products to the UK from
or via the European Union to get trader ready, reroute their supply chains away from
any potential disruption and stockpile on UK soil where this is possible. The letter
is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/letter-to-medicines-and-medical-products-suppliers-17-november-2020"
target="_blank">https://www.gov.uk/government/publications/letter-to-medicines-and-medical-products-suppliers-17-november-2020</a></p>
|
|
